ScoreWhy is Nanjing Well Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.39% and Operating profit at 10.82% over the last 5 years
2
Flat results in Sep 25
- INTEREST COVERAGE RATIO(Q) Lowest at 2,125.64
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.99 times
- OPERATING PROFIT(Q) Lowest at CNY 43.92 MM
3
With ROE of 8.07%, it has a expensive valuation with a 2.11 Price to Book Value
- Over the past year, while the stock has generated a return of 0.73%, its profits have risen by 12.1% ; the PEG ratio of the company is 2.2
- At the current price, the company has a high dividend yield of 1.5
4
Underperformed the market in the last 1 year
- The stock has generated a return of 0.73% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Nanjing Well Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Chemicals & Petrochemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nanjing Well Pharmaceutical Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Nanjing Well Pharmaceutical Co., Ltd.
1.96%
0.66
40.06%
China Shanghai Composite
21.43%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.67%
EBIT Growth (5y)
9.12%
EBIT to Interest (avg)
13.70
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.58
Tax Ratio
15.38%
Dividend Payout Ratio
53.83%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.61%
ROE (avg)
7.02%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
1.78
EV to EBIT
19.70
EV to EBITDA
12.50
EV to Capital Employed
1.73
EV to Sales
2.54
PEG Ratio
3.13
Dividend Yield
4.15%
ROCE (Latest)
8.76%
ROE (Latest)
8.03%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 233.26 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 8.34 %
RAW MATERIAL COST(Y)
Fallen by -14.98% (YoY
CASH AND EQV(HY)
Highest at CNY 862.33 MM
NET SALES(Q)
Highest at CNY 356.3 MM
PRE-TAX PROFIT(Q)
Highest at CNY 43.92 MM
-10What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.99 times
INTEREST COVERAGE RATIO(Q)
Lowest at 1,244.42
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.93 times
INTEREST(Q)
Highest at CNY 3.85 MM
OPERATING PROFIT(Q)
Lowest at CNY 47.89 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 13.44 %
Here's what is working for Nanjing Well Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 233.26 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Lowest at 8.34 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales
Highest at CNY 356.3 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 43.92 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Cash and Eqv
Highest at CNY 862.33 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -14.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Nanjing Well Pharmaceutical Co., Ltd.
Interest
At CNY 3.85 MM has Grown at 44.73%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 1,244.42
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debtors Turnover Ratio
Lowest at 4.99 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Interest
Highest at CNY 3.85 MM
in the last five periods and Increased by 44.73% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY 47.89 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 13.44 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Inventory Turnover Ratio
Lowest at 4.93 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
